Nanoform Finland Plc (NANOFH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nanoform Finland Plc (NANOFH) has a cash flow conversion efficiency ratio of -0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.38 Million ≈ $-3.95 Million USD) by net assets (€44.58 Million ≈ $52.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NANOFH market cap for the company's overall valuation and market capitalisation.
Nanoform Finland Plc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Nanoform Finland Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Nanoform Finland Plc for real-time trading data and today's change.
Nanoform Finland Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanoform Finland Plc ranked by their cash flow conversion efficiency. Review Nanoform Finland Plc financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fortune Parts Industry Public Company Limited
BK:FPI
|
0.028x |
|
Asia Pacific Satellite Inc
KQ:211270
|
0.011x |
|
Gan Shmuel
TA:GSFI
|
0.035x |
|
Kootenay Silver Inc
V:KTN
|
-0.025x |
|
JW Shinyak Corporation
KQ:067290
|
0.115x |
|
Alcadon Group AB
ST:ALCA
|
0.063x |
|
Solitario Exploration & Royalty Corp
NYSE MKT:XPL
|
-0.019x |
|
NICE Total Cash Management Co. Ltd
KQ:063570
|
0.149x |
Annual Cash Flow Conversion Efficiency for Nanoform Finland Plc (2017–2024)
The table below shows the annual cash flow conversion efficiency of Nanoform Finland Plc from 2017 to 2024. Also see NANOFH total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €60.03 Million ≈ $70.18 Million |
€-18.28 Million ≈ $-21.37 Million |
-0.304x | -13.22% |
| 2023-12-31 | €66.95 Million ≈ $78.27 Million |
€-18.00 Million ≈ $-21.05 Million |
-0.269x | -16.79% |
| 2022-12-31 | €87.21 Million ≈ $101.96 Million |
€-20.08 Million ≈ $-23.48 Million |
-0.230x | -35.58% |
| 2021-12-31 | €84.49 Million ≈ $98.78 Million |
€-14.35 Million ≈ $-16.78 Million |
-0.170x | +24.86% |
| 2020-12-31 | €62.64 Million ≈ $73.23 Million |
€-14.16 Million ≈ $-16.55 Million |
-0.226x | +69.08% |
| 2019-12-31 | €7.93 Million ≈ $9.27 Million |
€-5.80 Million ≈ $-6.78 Million |
-0.731x | -144.64% |
| 2018-12-31 | €5.03 Million ≈ $5.88 Million |
€-1.50 Million ≈ $-1.76 Million |
-0.299x | -111.03% |
| 2017-12-31 | €-246.96K ≈ $-288.72K |
€-669.18K ≈ $-782.34K |
2.710x | -- |
About Nanoform Finland Plc
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) na… Read more